Ambea AB (FRA:6MA) Other Current Liabilities: €158 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6MA Ambea AB FRA:6MA
84 GF Score
Price €12.93
GF Value €10.90
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Ambea AB Other Current Liabilities?

Ambea AB FRA:6MA -0.08% 84 Other Current Liabilities is €158 Mil as of Mar. 2026. GuruFocus rates FRA:6MA with a GF Score™ of 84/100 and a GF Value™ of €10.90 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Ambea AB's other current liabilities for the quarter that ended in Mar. 2026 was €158 Mil.

Ambea AB's quarterly other current liabilities declined from Sep. 2025 (€143 Mil) to Dec. 2025 (€140 Mil) but then increased from Dec. 2025 (€140 Mil) to Mar. 2026 (€158 Mil).

Ambea AB's annual other current liabilities increased from Dec. 2023 (€109 Mil) to Dec. 2024 (€122 Mil) and increased from Dec. 2024 (€122 Mil) to Dec. 2025 (€140 Mil).

Ambea AB Other Current Liabilities Related Terms

Ambea AB Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Ambea AB's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambea AB Other Current Liabilities Chart

Ambea AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 128.81 120.43 108.53 122.23 139.86

Ambea AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 144.33 77.55 142.90 139.86 158.48
FRA:6MA
84GF Score
Ambea AB FRA:6MA
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambea AB Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €158 Mil mean?
Ambea AB (FRA:6MA) has a Other Current Liabilities of €158 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Ambea AB.
Is Ambea AB's Other Current Liabilities too high?
Ambea AB's current Other Current Liabilities is €158 Mil. Overall, Ambea AB has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ambea AB's Other Current Liabilities compare to HCA and THC?
Ambea AB's Other Current Liabilities of €158 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Healthcare Providers & Services company?
A good Other Current Liabilities depends on the Healthcare Providers & Services industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Ambea AB. Ambea AB's current Other Current Liabilities is €158 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambea AB stock overvalued right now?
Based on GuruFocus' analysis, Ambea AB (FRA:6MA) is currently considered Modestly Overvalued. The stock's GF Value™ is €10.90, compared to a current price of €12.93 — trading 18.6% above its estimated fair value. The current Other Current Liabilities is €158 Mil. Ambea AB's overall GF Score™ is 84/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Ambea AB (FRA:6MA), the current Other Current Liabilities is €158 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ambea AB (FRA:6MA) Overvalued in 2026?

Based on GuruFocus' analysis, Ambea AB stock appears to be overvalued. The current stock price of €12.93 is trading 18.6% above its estimated GF Value™ of €10.90. GuruFocus considers Ambea AB to be Modestly Overvalued.

Key valuation signals for FRA:6MA:

  • Other Current Liabilities: €158 Mil
  • GF Value™: €10.90 vs. price of €12.93 (18.6% above fair value)
  • GF Score™: 84/100 with 8 warning signs

No single metric tells the full story. See the FRA:6MA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ambea AB Business Description

Address Rontgenvagen 3D, Box 1565, Solna, Stockholm, SWE, 171 29
Ambea AB is a Swedish care-provider group focused on elderly care, disability care, psychosocial support, housing, staffing, and training across the Nordic region. The company's segment includes: i) Nytida: Comprises social care services for children, youth and adults, in Sweden, ii) Vardaga: Comprises nursing homes and home care in Sweden, iii) Stendi: Comprises social care for children, youth and adult in Norway, iv) Validia: Comprises social care for children, v) Altiden: Comprises social care for children, youth and adults as well as elderly care in Denmark, and vi) Klara: Comprises competence and staffing solutions for elderly and social care, and student health services in Sweden. The majority of the company's revenue is derived from the Vardaga segment.
84GF Score

Get the complete analysis for FRA:6MA

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.93
Price
€10.90
GF Value